Klinikum der Universitaet Muenchen AöR
Klinikum der Universitaet Muenchen AöR is recorded as a service provider in 7 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 7 of 7 trials · Latest update first
A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with primary progressive multiple sclerosis (PERSEUS)
Sponsor Genzyme Corp.
- Start (EU)
- Latest update
- Estimated end
Glofitamab Combined With Pirtobrutinib in Relapsed/Refractory Patients with Mantle Cell Lymphoma Followed by an Extension in Treatment Naïve Patients (PLATO)
Sponsor Klinikum der Universitaet Muenchen AöR
- Start (EU)
- Latest update
- Estimated end
- Not reported
TherVacB – A multi-center phase 1b/2a trial to assess safety, tolerability and immunogenicity of a heterologous protein prime/MVA boost therapeutic hepatitis B vaccine candidate
Sponsor Klinikum der Universitaet Muenchen AöR
- Start (EU)
- Latest update
- Estimated end
A single dose of apixaban for the prevention of thrombotic events in the context of long-distance flights (DANCE FLIGHT)
Sponsor Klinikum der Universitaet Muenchen AöR
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Venetoclax in combination with the BTK inhibitor Ibrutinib and Rituximab or conventional chemotherapy (Bendamustine) and Ibrutinib and Rituximab in patients with treatment naive Mantle Cell Lymphoma not eligible for high dose therapy
Sponsor Universitatsmedizin der Johannes Gutenberg-Universitat Mainz KöR
- Start (EU)
- Latest update
- Estimated end
- Not reported
An open label, long-term extension study to evaluate the safety and efficacy of CRN00808 in subjects with acromegaly (ACROBAT ADVANCE)
Sponsor Crinetics Pharmaceuticals Inc.
- Start (EU)
- Latest update
- Estimated end
A Randomized, Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Paltusotine in Subjects with Acromegaly Treated with Long-acting Somatostatin Receptor Ligands
Sponsor Crinetics Pharmaceuticals Inc.
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Klinikum der Universitaet Muenchen AöR?
The 2026-10-09 snapshot links Klinikum der Universitaet Muenchen AöR to 7 distinct CTIS trials. Recorded services include Data management, Safety reporting & pharmacovigilance, Statistical analysis, Electronic data capture, among 10 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Klinikum der Universitaet Muenchen AöR?
The most frequently recorded therapeutic areas are Haematological Malignancies, Hepatology, Immunology, Infectious Disease. Recorded phases include Phase 2, Phase 1, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Klinikum der Universitaet Muenchen AöR conducted?
The linked trials record locations in 19 countries, including Germany, Spain, Hungary, Italy, Belgium. These are trial locations, not confirmed office locations or countries where Klinikum der Universitaet Muenchen AöR delivered services.
What can this page tell me about Klinikum der Universitaet Muenchen AöR's trial experience?
Browse 7 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Klinikum der Universitaet Muenchen AöR. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Klinikum der Universitaet Muenchen AöR